Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luohuazizhu Granule basket trial in acute tonsillitis, nonvariceal upper gastrointestinal bleeding, and urinary tract infection with bleeding
ChiCTR2300072261Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of luohuazizhu in acute tonsillitis, upper gastrointestinal bleeding (UGIB) and urinary tract infection (UTI) (6 arms), sponsored by Second Affiliated Hospital of Heilongjiang University of Chinese Medicine. Primary endpoints: Improvement of pharyngeal pain VAS score compared with baseline, Negative conversion rate of fecal occult blood and 1 more. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
luohuazizhu
03
Conditions
acute tonsillitisupper gastrointestinal bleeding (UGIB)urinary tract infection (UTI)
Beyond the preview
Go deeper on ChiCTR2300072261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072261.